Bayer Healthcare & Tsinghua University
Bayer-Tsinghua Joint Symposium on
Joint Research Center for Innovative Drug Discovery
Tsinghua University, Beijing, China
Medical School Building, Room B323
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | |
| | | | | | | How to Discover the Drugs of the Future - Lead Finding Strategies at Bayer HealthCare
|
| | | | | | | Adenosine receptor agonists and Kinase inhibitors: 2 case studies for successful lead discovery
|
| | | | | | | Establishment of Enabling Technologies for
Biological Research & Development.
|
| | | | | | | Oncology Research at Bayer: Novel targeted Therapies – with focus on Antibody-Drug-Conjugates
|
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | |
Prof. Yigong Shi - Tsinghua University; Dean of School of Life Sciences, Senior Vice Dean of School of Medicine
Prof. Hanno Wild - Bayer HealthCare; Senior Vice President, Global Drug Discovery, Global Candidate Generation and Exploration
Dr. Helmut Haning - Bayer HealthCare; Senior Vice President, Global Drug Discovery, Global Innovation Sourcing
Dr. Anette Sommer - Bayer HealthCare; Principal Scientist, Global Drug Discovery, Immunotherapy & Antibody Drug conjugates
Dr. Jennifer Hu - Bayer HealthCare; Vice President, Global Drug Discovery, Innovation Center China
Prof. Liangzhi Xie - President and CEO Sino Biological Inc., Professor at Peking Union Medical College
